OBJECTIVE-Chronic hypoxia has been recognized as a key regulator in renal tubulointerstitial fibrosis, as seen in diabetic nephropathy, which is associated with the activation of hypoxia-inducible factor (HIF)-1 alpha. We assess here the effects of the biguanide, metformin, on the expression of HIF-1 alpha in diabetic nephropathy using renal proximal tubular cells and type 2 diabetic rats. RESEARCH DESIGN AND METHODS-We explored the effects of metformin on the expression of HIF-1 alpha using human renal proximal tubular epithelial cells (HRPTECs). Male Zucker diabetic fatty (ZDF; Gmi-fa/fa) rats were treated from 9 to 39 weeks with metformin (250 mg kg(-1) . day(-1)) or insulin. RESULTS- Metformin inhibited hypoxia-induced HIF-1 alpha accumulation and the expression of HIF-1-targeted genes in HRPTECs. Although metformin activated the downstream pathways of AMP-activated protein kinase (AMPK), neither the AMPK activator, AICAR, nor the mTOR inhibitor, rapamycin, suppressed hypoxia-induced HIF-1 alpha expression. In addition, knockdown of AMPK-a did not abolish the inhibitory effects of metformin on HIF-1 alpha expression. The proteasome inhibitor, MG-132, completely eradicated the suppression of hypoxia-induced HIF-1 alpha accumulation by metformin. The inhibitors of mitochondrial respiration similarly suppressed hypoxia-induced HIF-1 alpha expression. Metformin significantly decreased ATP production and oxygen consumption rates, which subsequently led to increased cellular oxygen tension. Finally, metformin, but not insulin, attenuated tubular HIF-1 alpha expression and pimonidazole staining and ameliorated tubular injury in ZDF rats. CONCLUSIONS-Our data suggest that hypoxia-induced HIF-1 alpha accumulation in diabetic nephropathy could be suppressed by the antidiabetes drug, metformin, through the repression of oxygen consumption. Diabetes 60:981-992, 2011
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据